Skip to main content
. Author manuscript; available in PMC: 2015 Sep 2.
Published in final edited form as: Int J Hyg Environ Health. 2013 Apr 30;217(0):176–187. doi: 10.1016/j.ijheh.2013.04.006

Table 3.

Standardized mortality ratios overall and by duration of employment, NIOSH Capacitor Cohort, 1960–2008.a

Underlying cause of deathb Entire cohort (n = 24,865)
Short-term workersc (n = 7647)
Long-term workersc (n = 17,218)
OBS SMRd 95% CI OBS SMR 95% CI OBS SMR 95% CI
All causes 8688 0.99 0.97–1.01 2255 1.17 1.12–1.22 6433 0.94 0.91–0.96
All cancers 2593 1.06 1.02–1.10 686 1.20 1.11–1.30 1907 1.01 0.97–1.06
MN of buccal cavity and pharynx 45 1.12 0.82–1.50 17 1.89 1.10–3.03 28 0.90 0.60–1.29
  MN of tongue 12 1.25 0.65–2.18 3 1.38 0.28–4.02 9 1.21 0.55–2.30
  MN of other parts of buccal cavity 15 1.36 0.76–2.24 4 1.67 0.46–4.28 11 1.27 0.64–2.28
  MN of pharynx 18 0.94 0.56–1.48 10 2.31 1.11–4.25 8 0.54 0.23–1.06
MN of digestive organs and peritoneum 603 1.09 1.00–1.18 151 1.23 1.04–1.44 452 1.05 0.95–1.15
  MN of esophagus 60 1.21 0.92–1.55 10 0.90 0.43–1.66 50 1.29 0.96–1.71
  MN of stomach 58 1.04 0.79–1.35 12 1.01 0.52–1.77 46 1.05 0.77–1.40
  MN of intestine except rectum 231 1.11 0.97–1.27 56 1.23 0.93–1.60 175 1.08 0.92–1.25
  MN of rectum 50 1.21 0.90–1.59 9 0.98 0.45–1.85 41 1.27 0.91–1.73
  MN of biliary passages, liver and gall bladder 63 0.98 0.76–1.26 19 1.29 0.78–2.01 44 0.89 0.65–1.20
  MN of pancreas 136 1.08 0.90–1.28 42 1.47 1.06–1.98 94 0.96 0.78–1.18
  MN of peritoneum and other and unspecified of digestive organs 5 0.53 0.17–1.24 3 1.40 0.29–4.10 2 0.27 0.03–0.99
MN of respiratory system 797 1.08 1.00–1.15 230 1.35 1.19–1.54 567 0.99 0.91–1.08
  MN of larynx 24 1.32 0.85–1.97 8 2.04 0.88–4.02 16 1.13 0.64–1.83
  MN of trachea, bronchus, and lung 766 1.07 0.99–1.15 221 1.34 1.17–1.53 545 0.99 0.91–1.07
  MN other parts of respiratory system 7 1.52 0.61–3.14 1 0.91 0.02–5.09 6 1.71 0.63–3.72
MN of breast 239 1.01 0.89–1.15 74 1.15 0.90–1.44 165 0.96 0.82–1.12
MN of female genital organs 143 1.00 0.84–1.18 39 1.03 0.73–1.41 104 0.99 0.81–1.20
  MN of cervix uteri 31 1.12 0.76–1.60 10 1.29 0.62–2.37 21 1.06 0.66–1.62
  MN of other and unspecified parts of uterus 34 1.07 0.74–1.50 6 0.75 0.28–1.63 28 1.18 0.78–1.70
  MN of ovary, fallopian tube, and broad ligament 69 0.88 0.68–1.11 20 0.96 0.59–1.48 49 0.85 0.63–1.13
  MN of other female genital organs 9 1.75 0.80–3.32 3 2.38 0.49–6.95 6 1.54 0.57–3.36
MN of male genital organs 87 0.96 0.77–1.18 9 0.57 0.26–1.09 78 1.04 0.82–1.30
  MN of prostate 87 0.99 0.80–1.23 9 0.61 0.28–1.16 78 1.07 0.85–1.34
MN of urinary organs 109 1.08 0.89–1.31 31 1.43 0.97–2.02 78 0.99 0.78–1.24
  MN of kidney 56 1.03 0.78–1.34 14 1.12 0.61–1.88 42 1.01 0.73–1.36
  MN of bladder and other urinary organs 53 1.15 0.86–1.50 17 1.84 1.07–2.95 36 0.97 0.68–1.35
MN of other and unspecified sites 335 1.06 0.95–1.18 80 1.06 0.84–1.32 255 1.06 0.94–1.20
  MN of bone 6 1.12 0.41–2.44 3 2.25 0.46–6.59 3 0.75 0.15–2.18
  Melanoma 47 1.20 0.88–1.60 6 0.60 0.22–1.30 41 1.41 1.01–1.91
  Other MN of skin 9 0.93 0.42–1.76 4 1.87 0.51–4.78 5 0.66 0.21–1.54
  Mesothelioma 7 1.53 0.61–3.15 1 0.94 0.02–5.26 6 1.70 0.62–3.71
  MN of connective tissue 14 0.94 0.51–1.57 3 0.78 0.16–2.27 11 0.99 0.50–1.77
  MN of brain and other parts of nervous system 67 1.01 0.78–1.28 14 0.83 0.45–1.39 53 1.07 0.80–1.40
  MN of thyroid gland 3 0.52 0.11–1.53 0 0.00 0.00–2.76 3 0.68 0.14–2.00
  MN of other and unspecified sites 181 1.07 0.92–1.24 49 1.27 0.94–1.68 132 1.02 0.85–1.21
Neoplasms of lymphatic and hematopoietic tissue 235 1.01 0.88–1.15 55 1.02 0.77–1.33 180 1.01 0.86–1.16
  Hodgkin disease 9 0.76 0.35–1.45 4 1.28 0.35–3.27 5 0.58 0.19–1.35
  Non-Hodgkin lymphoma 93 0.99 0.80–1.21 24 1.11 0.71–1.65 69 0.95 0.74–1.20
  Multiple myeloma 45 1.12 0.82–1.50 4 0.45 0.12–1.14 41 1.31 0.94–1.78
  Leukemia and aleukemia 88 1.02 0.82–1.25 23 1.15 0.73–1.73 65 0.98 0.75–1.24
Benign and unspecified neoplasms 30 0.90 0.61–1.29 9 1.19 0.54–2.25 21 0.82 0.51–1.26
Tuberculosis and HIV-related disease 47 1.23 0.91–1.64 32 2.80 1.91–3.95 15 0.56 0.32–0.93
  Respiratory tuberculosis 3 0.47 0.10–1.36 1 0.81 0.02–4.50 2 0.38 0.05–1.39
  HIV-related 44 1.45 1.06–1.95 31 3.13 2.13–4.44 13 0.64 0.34–1.09
Diseases of the blood and blood forming organs 32 0.89 0.61–1.25 3 0.38 0.08–1.12 29 1.02 0.69–1.47
Diabetes mellitus 206 0.91 0.79–1.04 54 1.05 0.79–1.36 152 0.87 0.74–1.02
Mental, psychoneurotic, and personality disorders 113 0.84 0.69–1.01 39 1.40 0.99–1.91 74 0.69 0.54–0.87
  Alcoholism 19 0.60 0.36–0.94 10 1.20 0.58–2.21 9 0.39 0.18–0.74
  Other mental disorders 94 0.91 0.74–1.12 29 1.48 0.99–2.12 65 0.78 0.60–0.99
    Dementia and Alzheimer diseasee 116 1.04 0.86–1.24 32 1.57 1.08–2.22 84 0.92 0.73–1.14
Disorders of the nervous system and sense organs 254 1.09 0.96–1.24 60 1.22 0.93–1.57 194 1.06 0.92–1.22
  Multiple sclerosis 14 0.91 0.50–1.53 3 0.68 0.14–1.98 11 1.01 0.50–1.81
  Other diseases of the nervous system and sense organs 240 1.11 0.97–1.26 57 1.27 0.96–1.65 183 1.07 0.92–1.23
    Amyotrophic lateral sclerosise 31 1.34 0.91–1.90 11 1.95 0.97–3.50 20 1.14 0.70–1.76
    Parkinson diseasee 45 1.14 0.83–1.52 3 0.42 0.09–1.22 42 1.30 0.94–1.76
Diseases of the heart 2520 0.96 0.92–1.00 593 1.14 1.05–1.23 1927 0.92 0.87–0.96
  Rheumatic heart disease, including fever 28 0.71 0.47–1.03 6 0.71 0.26–1.55 22 0.71 0.45–1.08
  Hypertension with heart disease 60 0.71 0.54–0.92 19 1.07 0.65–1.68 41 0.62 0.44–0.84
  Ischemic heart disease 1984 0.96 0.92–1.01 454 1.12 1.02–1.23 1530 0.92 0.88–0.97
  Chronic disease of endocardium 44 0.87 0.63–1.17 7 0.69 0.28–1.42 37 0.91 0.64–1.26
  Cardiomyopathy 86 1.08 0.86–1.33 27 1.50 0.99–2.18 59 0.96 0.73–1.23
  Conduction disorder 148 1.08 0.91–1.27 42 1.46 1.05–1.98 106 0.98 0.80–1.19
  Other diseases of the heart 170 0.98 0.84–1.14 38 1.12 0.79–1.54 132 0.95 0.79–1.12
Other diseases of the circulatory system 734 0.96 0.89–1.03 136 0.89 0.74–1.05 598 0.98 0.90–1.06
  Cerebrovascular disease 478 0.94 0.85–1.02 89 0.88 0.71–1.09 389 0.95 0.86–1.05
  Hypertension without heart disease 43 0.96 0.69–1.29 3 0.32 0.07–0.95 40 1.12 0.80–1.53
  Diseases of the arteries, veins and lymphatic vessel 213 1.02 0.88–1.16 44 1.02 0.74–1.37 169 1.02 0.87–1.18
Diseases of the respiratory system 725 0.98 0.91–1.06 196 1.29 1.11–1.48 529 0.91 0.83–0.99
  Influenza 3 0.59 0.12–1.73 0 0.00 0.00–3.67 3 0.74 0.15–2.15
  Pneumonia (except newborn) 213 1.07 0.93–1.23 51 1.32 0.98–1.74 162 1.01 0.86–1.18
  Chronic obstructive pulmonary disease 400 1.00 0.91–1.10 118 1.40 1.16–1.68 282 0.90 0.79–1.01
  Asthma 16 0.97 0.55–1.57 6 1.47 0.54–3.21 10 0.80 0.38–1.47
  Other respiratory diseases 89 0.81 0.65–1.00 21 0.90 0.56–1.38 68 0.78 0.61–0.99
Diseases of the digestive system 320 0.85 0.76–0.95 96 1.11 0.90–1.36 224 0.78 0.68–0.89
Diseases of the skin and subcutaneous tissue 8 0.75 0.32–1.48 0 0.00 0.00–1.58 8 0.96 0.41–1.89
Diseases of the musculoskeletal system and connective system 33 0.85 0.58–1.19 10 1.09 0.52–2.00 23 0.78 0.49–1.16
Diseases of the genito-urinary system 136 0.89 0.75–1.05 34 1.08 0.74–1.50 102 0.84 0.69–1.02
  Chronic and unspecified nephritis and renal failure and other renal sclerosis 90 1.12 0.90–1.38 25 1.46 0.95–2.16 65 1.03 0.80–1.32
Symptoms and ill-defined conditions 45 0.52 0.38–0.70 16 0.79 0.45–1.29 29 0.44 0.29–0.63
Transportation injuries 167 0.78 0.66–0.91 60 0.94 0.72–1.21 107 0.71 0.58–0.86
Falls 39 0.70 0.50–0.96 2 0.17 0.02–0.61 37 0.85 0.60–1.17
Other injury 120 0.79 0.66–0.95 49 1.19 0.88–1.57 71 0.65 0.50–0.81
Intentional self-harm 110 0.73 0.60–0.88 39 0.92 0.66–1.26 71 0.66 0.51–0.83
Assault and homicide 23 0.44 0.28–0.67 13 0.82 0.44–1.40 10 0.28 0.13–0.51
Other causes 207 0.91 0.79–1.04 64 1.17 0.90–1.49 143 0.82 0.69–0.97
Unknown cause 226 64 162

Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; OBS, observed deaths; MN, malignant neoplasm; SMR, standardized mortality ratio.

a

All results exclude workers who died (n = 61) or were lost to follow-up (n = 324) prior to the rate file begin date (1 January 1960).

b

International Classification of Disease (ICD) codes were mapped to underlying cause of death categories as described by Robinson et al. (2006) and tabulated on the NIOSH website (http://www.cdc.gov/niosh/ltas/rates.html). All major categories of causes of death are presented. Some minor categories of causes of death are not presented because there were two or fewer deaths in the category or the category was not of a priori interest and the SMR was not in statistically significant excess.

c

Short-term workers worked less than 3 months; long-term workers worked 3 months or longer.

d

The SMR is the ratio of observed to expected (based on US underlying cause of death rates, 1960–2007) deaths; 95% CI was estimated based on the Poisson distribution.

e

Neurodegenerative outcomes based on US underlying cause of death rates, 1960–2007. Dementia and Alzheimer disease (excluding arteriosclerotic dementia) includes ICD codes 304–305 (revision 7), 290.0–290.1 (revision 8), 290.0–290.3 and 331.0 (revision 9), and G30 (revision 10); amyotrophic lateral sclerosis includes ICD codes 306 (revision 7), 348.0 (revision 8), 335.2 (revision 9), and F01 (revision 10); and Parkinson disease includes ICD codes 350 (revision 7), 342 (revision 8), 332 (revision 9), and G20–G21 (revision 10).